Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd M Morgan

Showing results (161-170 of 307) with videos related to

Pageof 31
Sort By:
JCO Precision Oncology|August 25, 2020
Circulating Tumor Cells as a Predictor of Treatment Response in Clinically Localized Prostate CancerSimpa S Salami, Udit Singhal, Daniel E Spratt, et al.
Medical Oncology (Northwood, London, England)|July 24, 2019
Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution seriesJohn M Kennedy, Xiaoming Wang, Komal R Plouffe, et al.
The Journal of Urology|September 22, 2020
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART IWilliam T Lowrance, Rodney H Breau, Roger Chou, et al.
European Urology|May 27, 2019
The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus StatementMatthew R Cooperberg, Peter R Carroll, Marc A Dall'Era, et al.
BJU International|August 16, 2014
Hypoalbuminaemia is associated with mortality in patients undergoing cytoreductive nephrectomyAnthony T Corcoran, Samuel D Kaffenberger, Peter E Clark, et al.
Scientific Reports|January 28, 2026
Molecular profiling of primary versus paired asynchronous metastatic clear cell renal cell carcinoma reveals heterogeneity in tumor immune microenvironmentBrittney Cotta, Srinivas Nallandhighal, Steven Monda, et al.
The Journal of Urology|September 22, 2020
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART IIWilliam T Lowrance, Rodney H Breau, Roger Chou, et al.
Journal of Oncology Practice|August 11, 2017
Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline SummarySam S Chang, Bernard H Bochner, Roger Chou, et al.
Urologic Oncology|May 4, 2016
Standardizing the definition of adverse pathology for lower risk men undergoing radical prostatectomyMichael A Kozminski, Scott Tomlins, Adam Cole, et al.
The Journal of Urology|May 1, 2017
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO GuidelineSam S Chang, Bernard H Bochner, Roger Chou, et al.
Pageof 31

Showing results (161-170 of 307) with videos related to

Sort By:
Pageof 31
JCO Precision Oncology|August 25, 2020
Circulating Tumor Cells as a Predictor of Treatment Response in Clinically Localized Prostate CancerSimpa S Salami, Udit Singhal, Daniel E Spratt, et al.
Medical Oncology (Northwood, London, England)|July 24, 2019
Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution seriesJohn M Kennedy, Xiaoming Wang, Komal R Plouffe, et al.
The Journal of Urology|September 22, 2020
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART IWilliam T Lowrance, Rodney H Breau, Roger Chou, et al.
European Urology|May 27, 2019
The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus StatementMatthew R Cooperberg, Peter R Carroll, Marc A Dall'Era, et al.
BJU International|August 16, 2014
Hypoalbuminaemia is associated with mortality in patients undergoing cytoreductive nephrectomyAnthony T Corcoran, Samuel D Kaffenberger, Peter E Clark, et al.
Scientific Reports|January 28, 2026
Molecular profiling of primary versus paired asynchronous metastatic clear cell renal cell carcinoma reveals heterogeneity in tumor immune microenvironmentBrittney Cotta, Srinivas Nallandhighal, Steven Monda, et al.
The Journal of Urology|September 22, 2020
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART IIWilliam T Lowrance, Rodney H Breau, Roger Chou, et al.
Journal of Oncology Practice|August 11, 2017
Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline SummarySam S Chang, Bernard H Bochner, Roger Chou, et al.
Urologic Oncology|May 4, 2016
Standardizing the definition of adverse pathology for lower risk men undergoing radical prostatectomyMichael A Kozminski, Scott Tomlins, Adam Cole, et al.
The Journal of Urology|May 1, 2017
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO GuidelineSam S Chang, Bernard H Bochner, Roger Chou, et al.
Pageof 31